-
,for, Item ID-
- #1206997
- Diazyme Laboratories #10-0148
General Chemistry Reagent PLAC® Lp-PLA2 For Automated Clinical Chemistry Analyzers 250 Tests
REAGENT, PLAC TEST F/LP-PLA2 R1 1X36ML R2 1X9ML (250/BX) D/S
No Image
Features
- Diazyme's PLAC® Test is the only blood test cleared by the FDA to be used in conjunction with clinical evaluation and patient risk assessment as an aid in predicting risk of coronary heart disease (CHD) in patients with no prior history of cardiovascular events
- The PLAC® Test for Lp-PLA2 Activity is an enzyme assay for the in vitro quantitative determination of Lp-PLA2 (lipoprotein-associated phospholipase A2) activity in EDTA plasma and serum on automated clinical chemistry analyzers
- Lp-PLA2 activity is to be used in conjunction with clinical evaluation and patient risk assessment as an aid in predicting risk of coronary heart disease (CHD) in patients with no prior history of cardiovascular events
- More …
Product Details Email
Product Specifications
McKesson # | 1206997 |
---|---|
Manufacturer # | 10-0148 |
Brand | PLAC® |
Manufacturer | Diazyme Laboratories |
Country of Origin | United States |
Application | General Chemistry Reagent |
Container Type | Vial |
For Use With | For Automated Clinical Chemistry Analyzers |
Form | Liquid |
Number of Tests | 250 Tests |
Product Dating | McKesson Acceptable Dating: we will ship >= 90 days |
Sample Type | Serum / Plasma Sample |
Specialty | General Chemistry |
Test Category | Heart Health |
Test Method | Enzyme Cycling Method |
Test Name | Lp-PLA2 |
Test Type | Cardiac Marker |
UNSPSC Code | 41116105 |
Volume | R1: 36 mL, R2: 9 mL |
Features
- Diazyme's PLAC® Test is the only blood test cleared by the FDA to be used in conjunction with clinical evaluation and patient risk assessment as an aid in predicting risk of coronary heart disease (CHD) in patients with no prior history of cardiovascular events
- The PLAC® Test for Lp-PLA2 Activity is an enzyme assay for the in vitro quantitative determination of Lp-PLA2 (lipoprotein-associated phospholipase A2) activity in EDTA plasma and serum on automated clinical chemistry analyzers
- Lp-PLA2 activity is to be used in conjunction with clinical evaluation and patient risk assessment as an aid in predicting risk of coronary heart disease (CHD) in patients with no prior history of cardiovascular events
Professionals Also Viewed
-
,for, Item ID-
- #832497
- Providers like you icon 951
- Abbott Point of Care #07P0208
- Intended to be used for the in vitro quantitative determination of ala …
- CLIA Waived: Use lithium heparin whole blood, only
- Moderate Complexity: Use lithium heparin whole blood, lithium heparin …
-
,for, Item ID-
- #898768
- Providers like you icon 876
- Siemens #10317439
- USP Controlled Room Temperature
- A dip-and-read urinalysis product available for the CLINITEK Status® s …
- Clinitek® Microalbumin Strips provide albumin, creatinine and albumin- …
-
,for, Item ID-
- #1166840
- Providers like you icon 435
- Abbott Point of Care #09P31-26
- The i-STAT CHEM8+ cartridge with the i-STAT 1 System is intended for u …
- Each i-STAT single-use cartridge uses advanced biosensor technology th …
- To perform a test, 2 to 3 drops of blood are applied to a cartridge, w …
-
,for, Item ID-
- #581701
- Providers like you icon 422
- Abbott Point of Care #03P8425